GlassScriptPhysician profile
Jan W Duncan
NPI 1821109083
$85,771.36
in general payments reported to CMS, 2019-2025
24 companies · $47K in 2025
The $47K reported for 2025 was more than what 86% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $71.65 · 2021: $136 · 2022: $254 · 2023: $677 · 2024: $38K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $83K · Food and Beverage: $1,790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $83,300.00 |
| Food and Beverage | $1,789.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| L&K Spine INC | $83,300.00 | 2024-2025 | |
| Providence Medical Technology, INC. | $485.72 | 2021-2025 | |
| Gs Solutions, INC. | $320.62 | 2023 | |
| Spineart USA INC | $286.47 | 2023-2024 | Perla Tl |
| Medtronic, INC. | $250.16 | 2021-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Boston Scientific Corporation | $202.73 | 2023-2024 | Bodyguardian |
| Trice Medical, INC. | $200.00 | 2019 | |
| Baxter Healthcare | $160.46 | 2024-2025 | Floseal |
| Stryker Corporation | $107.25 | 2020-2024 | Airo |
| Amgen INC. | $66.25 | 2022 | |
| Integrity Implants INC. | $62.49 | 2022 | |
| Bioventus LLC | $44.80 | 2025 | |
| Smith+Nephew, INC. | $42.01 | 2024 | Pico |
| Merit Medical Systems INC | $35.31 | 2021-2022 | |
| Si-Bone, INC. | $35.31 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $27.00 | 2025 | Stimulan |
| Medacta USA, INC. | $25.16 | 2023 | Myspine |
| Fidia Pharma USA INC. | $22.26 | 2022 | |
| Zimmer Biomet Holdings, INC. | $20.35 | 2019 | |
| Orthofix Medical, INC. | $18.32 | 2024 | Spinal-Stim |
| Lemaitre Vascular, INC. | $17.36 | 2024 | Anastoclip Gc 8cm (Medium) |
| Nevro Corp. | $17.24 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.87 | 2022 | |
| Arteriocyte Medical Systems, INC. | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.